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Myocardial reperfusion after reversible regional isch-
emia is known to result in delayed recovery of contractile
function, but the mechanism responsible for this phe-
nomenon remains unclear. We examined the ability of
N-2-mercaptopropionylglycine, a synthetic thiol com-
pound with oxygen free radical scavenging properties,
to attenuate postischemic dysfunction in open chest dogs
undergoing a 15 minute occlusion of the left anterior
descending coronary artery followed by 4 hours of re-
perfusion. Treated animals received an infusion of N-2-
mercaptopropionylglycine (50 mg/kg per h) for 4 hours
starting 15 minutes before coronary occlusion. Collateral
flow, as determined with radioactive mlcrospheres after
10 minutes of ischemia, was 0.07 ± 0.01 mJlmin per g
(mean ± SE) in both control (n = 20) and treated (n
=13)groups. The occluded vascular bed, as determined
by postmortem perfusion, averaged 26.1 ± 1.2% ofthe
weight of the left ventricle in control and 29.6 ± 1.3%
in treated animals.
Myocardial reperfusion after reversible ischemia is associ-
ated with delayed recovery of contractile function in ex-
perimental models of coronary artery occlusion (l,2). Re-
cent observations strongly suggest that such myocardial
"stunning" (3) also occurs in humans, and may be of con-
siderable significance in various clinical settings of transient
ischemia followed by reperfusion (4-6). The ability to mod-
ify this postischemic dysfunction, however, has been limited
by a lack of understanding of its pathophysiology.
A growing body of evidence implicates oxygen free rad-
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Systolicwall thickening (an index of regional function)
was assessed with an epicardial pulsed Doppler probe.
The two groups exhibited comparable systolic thickening
under baseline conditions and similar degrees of dys-
kinesia during ischemia. Nevertheless, recovery of func-
tion (expressed as percent of baseline) was considerably
greater in the treated dogs at 1 hour (44.6 versus 12.8%,
p = 0.05), 2 hours (64.0 versus 31.6%, p < 0.02), 3
hours (77.1 versus 36.7%, p < 0.01) and 4 hours of
reperfusion (75.0 versus 40.0%, p < 0.05).
Thus, N-2-mercaptopropionylglycine produced a sig-
nificant and sustained improvement in recovery of con-
tractile function after a brief episode of regional myo-
cardial ischemia. These results suggest that oxygen free
radicals play a significant role in myocardial postlsch-
emic dysfunction. Because N-2-mercaptopropionylgly-
cine is potentially available for oral prophylactic ther-
apy, these results have significanttherapeutic implications.
(J Am Coil CardioI1986;8:1l61-8)
icals as mediators of reperfusion injury in a variety of organ
systems (7-11). We have recently demonstrated (12) that
the oxygen free radical scavengers superoxide dismutase
and catalase improve recovery of function after a brief ep-
isode of coronary artery occlusion. Because superoxide dis-
mutase and catalase eliminate the superoxide anion and hy-
drogren peroxide, respectively, these results suggest that
oxygen free radicals play an important role in the patho-
genesis of postischemic dysfunction. The application of these
enzymes to patients with coronary artery disease, however,
is at present limited by several factors, including the lack
of previous clinical utilization and the need for parenteral
administration. The demonstration that a free radical scav-
enger is effective in improving postischemic contractile
function would provide additional evidence to support the
role of oxygen free radicals in postischemic dysfunction,
and would also furnish important data relevant to potential
clinical applications.
N-2-mercaptopropionylglycine is an oxygen free radical
scavenger (13-16) that has been used clinically in Europe
0735-1097/86/$3.50
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and Japan in the treatment of several disorders linked to
abnormal free radical production (17-19). It can be admin-
istered orally and can theoretically scavenge both intracel-
lular and extracellular oxygen free radicals because of its
ability to cross the cell membrane. Its potential value in the
setting of ischemia and reperfusion is suggested by a recent
report (16) in which its use was associated with a significant
decrease in infarct size in a canine preparation of 90 minutes
of coronary occlusion followed by reperfusion. The purpose
of the present study was to determine whether N-2-mer-
captopropionylglycine enhances recovery of contractile
function after a reversible ischemic insult. Accordingly, we
used a canine model of 15 minutes of coronary artery oc-
clusion followed by reperfusion in which improved recovery
of function was previously observed with the use of super-
oxide dismutase and catalase (12). This duration of ischemia
was selected because it does not result in myocardial cell
necrosis (2,20), but nevertheless does produce delayed re-
covery of function (1-3).
Methods
This study was performed in accordance with the guide-
lines of the Committee on Animals of Baylor College of
Medicine and with the Guiding Principles in the Use and
Care of Animals approved by the American Physiological
Society.
Instrumentation. Mongrel dogs of both sexes weighing
IS to 31 kg were anesthetized with intravenous sodium
pentobarbital (30 mglkg), intubated and ventilated with room
air through a Harvard ventilator. Ventilatory variables were
adjusted on the basis of arterial blood gas determinations to
maintain normal pH and satisfactory oxygenation. The left
pleural cavity was entered through the fifth intercostal space
and the pericardium was incised. The left anterior descend-
ing coronary artery was isolated and encircled with a snare
at a site distal to the first major diagonal branch, to produce
an ischemic zone encompassing approximately one-quarter
of the left ventricle. A Doppler flow velocity probe was
placed around the artery distal to the site of occlusion.
Polyethylene catheters were inserted through the left carotid
artery into the aorta and through the left atrial appendage
into the left atrium, and connected to Statham P23Db pres-
sure transducers. An 8 French Millar pressure transducer
was introduced into the left ventricle through an apical stab
wound. A Doppler ultrasonic wall thickening probe (21)
was positioned over the portion of the left ventricle to be
rendered ischemic, and a second probe was placed on the
posterior left ventricular wall to serve as a control. The
Doppler probe consists of a 4 mm ultrasonic crystal bonded
to a 1.5 ern diameter fabric disk impregnated with Silastic.
The disk was secured to the epicardial surface with inter-
rupted 6-0 Prolene sutures placed 0.5 to I mm into the
myocardium, thus producing only minimal trauma. Aortic
pressure, left ventricular pressure, first derivative of left
ventricular pressure (dP/dt), left atrial pressure, left anterior
descending blood flow velocity, myocardial thickening and
lead II of the electrocardiogram were recorded on an eight
channel Gould-Brush recorder (200 series).
Protocol. Treated dogs received a continuous infusion
of N-2-mercaptopropionylglycine (Sigma Chemical Co.),
50 mg/kg per h, in normal saline solution for 4 hours starting
15 minutes before coronary occlusion. Control dogs re-
ceived saline solution alone. The infusion was administered
directly into the left ventricle through the Millar catheter at
a rate of 25 mllh. The left anterior descending coronary
artery was occluded for 15 minutes and then reperfused.
Restoration of flow was confirmed by noting the immediate
reactive hyperemic response detected by the coronary flow
velocity probe. No attempt was made to resuscitate animals
that developed ventricular fibrillation during ischemia or
reperfusion. Hemodynamic and wall thickening data were
obtained before and after 5 minutes of ischemia, and at I,
2, 3 and 4 hours of reperfusion. At the conclusion of the
study, the dogs were given heparin (6,000 U) followed by
a lethal dose of potassium chloride, and the hearts were
excised.
Quantification of occluded vascular bed. A postmor-
tem dual perfusion technique was used to determine the size
of the occluded coronary vascular bed (12). Two cannulas
were inserted immediately proximal and distal to the site of
the previous coronary artery occlusion. The distal left an-
terior descending coronary bed was perfused with normal
saline solution. The proximal left anterior descending and
circumflex arteries were perfused retrogradely with a 0.5%
solution of Monastral blue dye in saline, while digitally
occluding the left coronary ostium. The two vascular beds
were perfused simultaneously for 2 minutes at equal phys-
iologic pressure (100 mm Hg). The heart was then cut into
1.0 em slices in a plane parallel to the atrioventricular groove,
and all atrial, valvular and right ventricular tissue was ex-
cised. The slices were incubated in a I% solution of tri-
phenyltetrazolium chloride for 20 minutes at 38°C to verify
the absence of irreversible injury. This agent stains only
viable myocardium containing dehydrogenase dark red (22).
The portion of the left ventricle supplied by the previously
occluded coronary artery (occluded coronary bed) was iden-
tified by the absence of Monastral blue dye, and separated
from the rest of the left ventricle. Both components were
weighed to determine occluded bed size as a percent of the
left ventricle.
Regional myocardial blood flow. Regional myocardial
blood flow was determined by the radioactive microsphere
technique (23) IO minutes after coronary occlusion. Micro-
spheres 15 ± 3 JLm in diameter (Dupont Co.), labeled with
scandium-46, strontium-85, tin-l13 or cerium-141, were
obtained as I mCi of nuclide suspended in 10 ml of 10%
dextran containing Tween 80. After 2 minutes of vigorous
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mixing on a vortex agitator, approximately 2 million spheres
were suspended in 3 ml of normal saline solution and in-
jected into the left atrium over 10 seconds, after which the
catheter was flushed with an additional 10 ml of saline.
Beginning 15 seconds before and continuing for 2 minutes
after injection, a reference blood sample was withdrawn
from the aorta with a Harvard pump at a constant rate of
4.05 ml/rnin. After postmortem perfusion and triphenylte-
trazolium chloride staining, four transmural samples (1.0 to
1.5 g) were obtained from both the occluded and the non-
occluded beds. To avoid admixture of ischemic and non-
ischemic tissue, ischemic samples were obtained at least I
em inside the margin of the unstained region. The radio-
activity of the tissue and reference blood samples was de-
termined with a sodium iodide crystal well counter. Re-
gional myocardial blood flow was calculated by standard
methods (23) and expressed as milliliters per minute per
gram.
Regional myocardial function. Regional myocardial
function was assessed using a 10 MHz pulsed Doppler ul-
trasound wall thickening probe. Theoretical and experi-
mental validation of this technique has been previously pub-
lished (21,24). The pulsed Doppler technique utilizes a single
epicardial crystal to determine systolic myocardial wall dis-
placement by digitally integrating the velocity of myocardial
layers passing through the range gated sample volume. A
representative example of the wall thickening tracings ob-
tained with this probe is illustrated in Figure I. The begin-
ning and end of systole were determined from the onset of
the upstroke of the left ventricular pressure tracing and the
peak negative dP/dt, respectively. Systolic thickening frac-
tion was calculated by dividing net systolic thickening by
end-diastolic wall thickness as determined by the range gate
depth. Net systolic thickening was defined as the maximal
systolic increase in wall thickness from the end-diastolic
value (25). When paradoxical wall thinning persisted for
50% or more of systole, the maximal extent of wall thinning
was substracted from wall thickening (25). Thickening frac-
tion determined by the Doppler method correlates closely
with thickening fraction measured using two ultrasonic transit-
time crystals (21,24). The use of the Doppler probe is ad-
vantageous, however, in that the single epicardial crystal
eliminates the trauma of intramyocardial crystal insertion.
Statistical analysis. Data are expressed as group means
± SEM. The Student's unpaired t test was used to compare
mean values between control and treated animals, and a
probability value of less than 0.05 was considered statisti-
cally significant.
Results
Study animals. Of the 43 dogs initially instrumented,
4 from each group died of ventricular fibrillation immedi-
ately after reperfusion. The protocol was discontinued in
one control dog because coronary artery occlusion failed to
produce dyskinesia, and in one treated dog because occlu-
sion produced a marked decrease in global function such
that nonischemic zone contractile function decreased to 50%
of that obtained under baseline conditions, with continued
deterioration after reperfusion. Analysis of data was thus
carried out in 20 control and 13 treated dogs. Triphenyl-
tetrazolium chloride staining was uniformly present in the
REPERFUSION
BASELINE OCCLUSION Ih 4h
Figure 1. Representative wall thickening
tracings from one control animal. Systolic
wall thickening present under baseline
conditions was replaced by paradoxical
thinning (dyskinesia) during left anterior
descending artery occlusion. Dyskinesia
persisted at I hour of reperfusion, with
minimal recovery at 4 hours. From top
to bottom: left ventricularpressure (LVP),
change in wall thickness (WT) in the left
anterior descending artery territory and
left ventricular dP/dt. Vertical lines in-
dicate the beginning and end of systole.
Because the Doppler probe measures
changes in wall thickness rather than ab-
solute wall thickness, the position of the
signal on paper bears no relation to ab-
solute wall thickness.
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Table 1. Hemodynamic Variables in Control (n = 20) and Treated (n = 13) Dogs Before, During and After a 15 Minute Occlusion
of the Left Anterior Descending Coronary Artery
Reperfusion
Baseline Ischemia I h 2 h 3h 4h
HR
Control 135 ± 4 138 ± 4 129 ± 5 126 ± 5 120 ± 5 115 ± 6
MPG 135 ± 4 136 ± 4 136 ± 5 136 ± 6 136 ± 5* 132 ± 5*
MAP
Control 109 ± 3 105 ± 4 100 ± 3 99 ± 3 99 ± 3 102 ± 4
MPG 105 ± 3 89 ± 5t 92 ± 3 100 ± 4 99 ± 5 99 ± 4
RPP
Control 16.7 ± 0.7 16.4 ± 0.7 15.0 ± 0.8 14.6 ± 0.8 13.6 ± 0.7 13.1 ± 0.8
MPG 16.3 ± 0.6 14.6 ± 0.7 15.3 ± 0.8 16.6 ± 1.1 16.6 ± 1.2* 15.9 ± 1.0*
LAP
Control 4.2 ± 0.3 6.3 ± 0.4 4.6 ± 0.4 3.5 ± 0.3 3.5 ± 0.3 3.6 ± 0.3
MPG 4.6 ± 0.3 5.4 ± 0.5 3.2 ± 0.3t 3.2 ± 0.3 3.9 ± 0.4 4.0 ± 0.5
*p < 0.05, tp < 0.01, tp < 0.02 versus control. Values are mean ± SE.
HR = heart rate (beats/min); LAP = mean left atrial pressure (mm Hg); MAP = mean arterial blood pressure (mm Hg); MPG = N-2-mercapto-
propionylglycine; RPP = rate-pressure product (heart rate x systolic blood pressure/I ,0(0).
previously ischemic myocardium, confirming the absence
of infarction in all animals.
Systemic hemodynamics (Table 1). There were no sig-
nificant differences between control and treated groups with
respect to baseline heart rate, mean arterial blood pressure,
rate-pressure product or mean left atrial pressure. The mean
arterial pressure was slightly lower in the treated dogs during
the 15 minutes of coronary occlusion (89 versus 105 mm
Hg), but was similar to the control group throughout re-
perfusion. During reperfusion the heart rate was slightly
greater in the treated group but the difference reached sta-
tistical significance only at 3 and 4 hours. This difference
was further reflected in the greater rate-pressure product in
the treated group during reperfusion.
Occluded bed size and regional myocardial blood flow
(Table 2). The two groups were closely comparable with
respect to both occluded bed size and coronary collateral
flow. Occluded bed size was 26. I ± 1.2% of the left ven-
tricular weight in the control group and 29.6 ± 1.3% in
the treated group. Transmural ischemic zone blood flow was
0.07 ± 0.01 mllmin per g in both groups. Blood flow to
the nonischemic region was also similar: I.I6 ± 0.09 mlJmin
per g in control and 0.97 ± 0.08 mllmin per g in treated
dogs.
Regional myocardial function. Systolic thickening
fraction in the control (nonischemic) region remained sim-
ilar in the two groups throughout the study (Table 3). Base-
line systolic thickening fraction in the territory to be ren-
dered ischemic averaged 32.8 ± 1.8% in the control and
32. I ± 1.8% in the treated dogs. Thickening fraction re-
mained virtually unchanged (32.9 ± 2.4%) after the initial
10 minutes of drug infusion. The results of serial measure-
ments of systolic thickening expressed as a percentage of
baseline are displayed in Figure 2. The two groups did not
differ with respect to the extent of systolic thinning (dys-
kinesia) during ischemia. Nevertheless, recovery offunction
after reperfusion was consistently greater in the animals
treated with N-2-mercaptopropionylglycine. After reperfu-
sion, thickening fraction (expressed as percent of baseline)
was 12.8 ± I 1.3% in control versus 44.6 ± 9.8% in treated
dogs (p = 0.05) at I hour, 31.6 ± 9.8 versus 64.0 ±
6. 1% (p < 0.02) at 2 hours, 36.7 ± 11.2 versus 77. I ±
5.3% (p < 0.01) at 3 hours and 40.0 ± I 1.5 versus 75.0
± 4.4% (p < 0.05) at 4 hours.
Table 2. Occluded Coronary Bed Size and Regional Myocardial Blood Flow
Control (n = 20)
MPG (n = 13)
P Value
Occluded Bed Weight
Left Ventricular
Weight (%)
26.1 ± 1.2
29.6 ± I.3
NS
Ischemic
Zone Flow
(mllmin per g)
0.07 ± 0.01
0.Q7 ± 0.01
NS
Nonischemic
Zone Flow
(mllmin per g)
1.16 ± 0.09
0.97 ± 0.08
NS
Values are mean ± SE. MPG = N-2-mercaptopropionylglycine.
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Table 3. Nonischemic Zone Systolic Thickening Fraction
Reperfusion
Baseline Occlusion 1 h 2 h 3 h
Control (n = 20) 23.4 ± 1.3 23.7 ± 1.2 22.0 ± 1.0 19.6 :': 0 .8 19.5 :': 1.0
MPG (n = 13) 22.4 ± 1.8 22.0 :': 2.1 20.6 :': 1.9 20.1 ± 1.7 19.8 :': 1.7
P Value NS NS NS NS NS
4h
19.1 :': 0.7
19.4 :': 1.7
NS
Values are mean:!: SE. MPG = N-2-mercaplopropionylgl ycine.
Discussion
This study demonstrates that the free radical scavenger
N-2-mercaptopropionylglycine produces a significant and
sustained improvement in recovery of myocardial function
after reversible regional ischemia. A 15 minute coronary
occlusion was selected because it does not result in my-
ocardia necrosis in the dog (2,20, 26, 27) . This was con-
firmed in the present study with the use of triphenyltetra-
zolium chloride staining. The ability of this enzyme-mapping
technique to delineate irreversible injury within hours of the
onset of ischemia, particularly when followed by reperfu-
sion, has been previously demonstrated (28,29). Thus , per-
sistent post ischemic dysfun ction was observed in this study
in the absence of irreversibl e damage, a finding consistent
with previous observations in similar models (1,2).
Several variables that might influence postischemic dys-
function were examined, but there were no differences be-
tween control and treated dogs that could account for the
beneficial effect observed . The two groups were virtually
identical with respect to regional function under baseline
conditions and collateral blood flow during coronary occlu-
sion. The size of the occluded vascular bed was slightly
greater in the treated group, a factor that if anything would
be expected to have an adverse rather than favorable effect
on recovery of function . The mean arterial pressure was
slightly lower in the treated dogs during the 15 minutes of
ischemia, but the rate-pressure product was similar in the
two groups . The similarity of the rate-pressure product dur-
ing coronary occlusion in control and treated dogs indicates
that the two groups were comparable with respect to myo-
cardial oxygen demands during the ischemic phase . The
difference in mean arterial pressure was not apparent during
the reperfu sion interval. Therefore, the enhanced myo-
cardial performance as detected by wall thickening in the
treated group at 1, 2, 3 and 4 hours of reperfusion cannot
be ascribed to reduced afterload . The heart rate was slightly
higher in the treated group during the latter part of the
reperfusion phase which would be expected to be deleterious
rather than beneficial. Thus, N-2-mercaptopropionylglycine
exerted a significant beneficial effect that was sustained even
during the late phase of reperfusion when the rate-pre ssure
product was greater in the treated group .
Postulated mechanisms of postischemic dysfunction.
The cause of the persistent contractile dysfunction after a
brief episode of myocardial ischemia unassociated with ne-
crosis rema ins unknown . Adenosine triphosphate levels de-
crease rapidly after coronary occlu sion (30) . Although there
appears to be a parallel between delayed replenishment of
adenosine triphosphate stores and delayed recovery of con-
tractile function after reperfusion (30,3 I), recent investi-
gations (32- 34) have failed to substantiate high energy
phosphate depletion as the primary cause of persistent post-
ischemic dysfunction. Other mechanisms that have been
postulated include a defect in the transfer of adenosine tri-
phosphate from the mitochondria to their site of utilization
(35), damage to contractile protein s (2) or disruption of
sympathetic neural responsiveness (36). We (12) have pre-
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Figure 2. Recovery of regional function in the left
anterior descending coronary artery territory after
15 minutes of occlusion in control (dashed line)
and treated (solid line) groups.
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viously shown that administration of the oxygen free radical
scavengers, superoxide dismutase plus catalase, improves
recovery of function after a 15 minute coronary occlusion.
The present study provides further evidence to support the
concept that oxygen free radicals playa significant role in
the pathogenesis of persistent contractile abnormalities after
reversible regional ischemia.
Oxygen free radicals in myocardial reperfusion in-
jury. Oxygen free radicals have been identified as mediators
of cell injury in a wide range of pathologic conditions (37-39).
Increasingly, interest has focused on the role of free radical
production in the setting of myocardial ischemia and re-
perfusion (9,39). Jolly et al. (40) demonstrated that the
combination of superoxide dismutase and catalase reduces
myocardial infarct size in a canine model of 90 minutes of
coronary artery occlusion followed by reperfusion. The
administration of free radical scavengers has produced im-
proved recovery of global left ventricular function after pro-
longed hypothermic global ischemia (41-43). In addition,
Burton (44) recently reported that superoxide dismutase im-
proves contractile performance after 1 hour of reperfusion
in an isolated, perfused rabbit septal preparation subjected
to 1 hour of ischemia. Our present data extend these ob-
servations to the dysfunction that occurs after regional myo-
cardial ischemia unassociated with necrosis in the intact
normothermic animal. Thus, our results suggest that even
a brief coronary occlusion can lead to the generation of toxic
oxygen metabolites in sufficient quantity to affect postisch-
emic contractility. Confirmation of the role of free radicals
in myocardial ischemia and reperfusion awaits the avail-
ability of a reliable method of measuring free radical pro-
duction in vivo.
Many biologic processes are known to result in the pro-
duction of oxygen free radicals (45,46). Nevertheless, the
mechanism of increased free radical production in tissues
subjected to ischemia and reperfusion remain speculative.
Both intracellular and extracellular sources have been pos-
tulated. Ischemia-induced mitochondrial damage may result
in impaired oxygen metabolism with concomitant free rad-
ical production when relatively high concentrations of ox-
ygen are restored at the time of reperfusion (37). Another
potential source of free radicals is the enzyme xanthine
oxidase, which, in the presence of oxygen, catalyzes the
conversion of hypoxanthine to xanthine with simultaneous
generation of superoxide anion (39). While one substrate
(hypoxanthine) accumulates during ischemia as a result of
adenosine triphosphate degradation, the other (molecular
oxygen) is provided by reperfusion, which could theoreti-
cally result in a burst of superoxide production. The evi-
dence regarding the significance of xanthine oxidase in myo-
cardial reperfusion injury is, however, contradictory (47--49).
A potential extracellular source of free radicals is the ac-
tivated neutrophil, which is known to produce superoxide
anion, hydrogen peroxide and the hydroxyl radical (50). It
has been demonstrated that neutrophil depletion results in
a significant decrease in myocardial infarct size (51), and
that activated leukocytes can disrupt sarcoplasmic reticulum
calcium transport through an oxygen radical mechanism
(52). Because N-2-mercaptopropionylglycine readily crosses
the cell membrane (53), it may protect from oxygen free
radicals generated in both the intracellular and extracellular
space.
N-Z-mercaptopropionylglycine. The antioxidant N-2-
mercaptopropionylglycine is a synthetic thiol compound that
scavenges the superoxide anion and, possibly, the hydroxyl
radical (13,14,16). In addition, the drug is able to substitute
as a sulphydryl donor for glutathione (53,54), an important
intracellular antioxidant that is significantly depleted by hy-
poxia and reperfusion (55). Glutathione functions as the
hydrogen donor for glutathione peroxidase, a protective en-
zyme that eliminates hydrogen peroxide and inactivates lipid
peroxides (55). Many of the deleterious effects of free rad-
icals are produced through lipid peroxidation of cellular and
subcellular membranes, with resulting changes in membrane
structure and function. N-2-mercaptopropionylglycine may,
therefore, exert its protective effect both through the direct
elimination of oxygen free radicals and through prevention
of lipid peroxidation (56).
Therapeutic benefit has been demonstrated with the use
of this agent in the treatment of rheumatoid arthritis (19)
and senile cataracts (17), two disorders that have been linked
to abnormal free radical production. In addition, studies in
several animal models (15) have demonstrated its efficacy
in ameliorating the side effects of radiation, a process whose
damaging effects are largely mediated through free radical
formation (45). N-2-mercaptopropionylglycine is readily
absorbed after oral administration (53) and is generally re-
ported to be a well tolerated drug (17,19).
Clinical implications. Although caution is obviously
warranted in extrapolating experimental data to humans, the
results of this study may have therapeutic implications.
Transient myocardial ischemia occurs in a variety of clinical
settings: unstable or variant angina, cardiac transplantation,
open heart surgery with cardioplegic arrest and patients with
acute myocardial infarction undergoing thrombolytic ther-
apy. Restoration of myocardial blood flow in these situations
may be associated with persistent, albeit reversible, depres-
sion of contractile function (3-6). Our results indicate that
such dysfunction may be effectively reduced with N-2-mer-
captopropionylglycine. Because of the potential benefit to
be derived from such an oral prophylactic agent, further
investigation of N-2-mercaptopropionylglycine appears
warranted.
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